Shares of NOTV are trading 17% higher today. Here's what's happening:

Shares of Inotiv Inc (NOTV) are trading 17% higher at a price of $12.52 at the time of this writing. The stock is riding a mix of good and bad news, although it appears traders are more bullish than bearish. The company is in the midst of a class action lawsuit, which some would think would drive the price down, but they also recently announced the acquisition of Protypia Inc for $11 million. The Nashville Tennessee based bio firm, Protypia, are experts in working with tissue-based protein research and peptides, which will allow (NOTV) to expand into those offerings.

Inotiv Inc has been trading between a 52-week high of $60.66 and a 52-week low of $9.14. The stock has a market cap of $319 Million.

Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market.